Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

29-Jan-2015 - AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move that puts it on a collision course with French Biotech, Cellectis.

Covance's LabCorp distraction will drive opportunities for CRL, says analyst

23-Jan-2015 - Investment firm William Blair has upgraded preclinical CRO Charles River Laboratories to ‘outperform’ based on strong toxicology demand and the pending acquisition of Covance.

Covance to offer teams of experts for early phase development services

21-Jan-2015 - Covance is looking to speed early drug development by setting up teams of experts to help sponsors bridge their preclinical and clinical development.

Charles River considers re-opening preclinical site in Massachusetts

15-Jan-2015 - CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the site perks up in the near future.

Crown expands Precos site to build caucasian cancer expertise

12-Jan-2015 - Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

Biotech defrauds NIH on $50m flu biologic contract

12-Jan-2015 - Ansun Biopharma will pay out over $2m (€1.6m) after committing fraud against the National Institutes of Health (NIH) to siphon money for cash flow problems.

PPD’s X-Chem signs multi-target collaboration with Janssen

12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.  

Horizon buys Haplogen chromosome tech for ‘10x’ faster cell production

09-Jan-2015 - Horizon says its £6m (€7.7m) purchase of Austrian biotech Haplogen Genomics means it can produce cell lines ten times faster than before using a haploid gene platform.

13 primates die at Covance Texas facility due to overheating

23-Dec-2014 - On two separate incidents in September and October, a total of 13 primates died at a Covance research facility in Alice, Texas due to hyperthermia.

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012. 

WIL IT software deal speed up US FDA drug evaluations? Yes says Instem

18-Dec-2014 - Regulatory reviewers spend more time managing incoming data than on the drug evaluation process, says Instem which has inked a deal with WIL Research for its nonclinical IT systems.

Horizon Discovery enters crowded CHO cell line market

09-Dec-2014 - Horizon Discovery Group announced Monday that its bioproduction division has shipped its first commercially available engineered CHO (Chinese Hamster Ovary) cell line for use in manufacturing of antibodies. 

CRO employee turnover rate falls as industry matures, survey finds

08-Dec-2014 - Over the last three years US turnover in clinical monitoring has dropped from 29.4% to 16.4% and globally overall company turnover has dropped from 27.2% to 14.2% on average, according...

European CRO Evotec looks to land huge strategic deal with Sanofi

03-Dec-2014 - Evotec and Sanofi have entered into exclusive negotiations for a major strategic partnership that will include a €250m ($310m) minimum guaranteed commitment from Sanofi over the next five years.

BMS-backed biopharma in pact with preclinical R&D experts

20-Nov-2014 - A preclinical biotech backed by Bristol-Myers Squibb is forming a strategic alliance with Synergy Partners R&D Solutions to boost academic discoveries.

Demand for early formulation work to tackle drug target ‘Wild West’

18-Nov-2014 - Sponsors are turning to outsourcing earlier for help with bioavailability formulation, say contract research organisations (CROs)

Ricerca Biosciences bought by private equity fund; 199 jobs saved says CEO

18-Nov-2014 - Ricerca Biosciences has been bought by private equity group Main Market Partners in a deal that means the contract research organisation's (CRO) 199 employees keep their jobs. 

GVK BIO steps into GLP tox with Vanta Bioscience acquisition

10-Nov-2014 - Indian CRO GVK BIO announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment CRO operating out of Chennai, India.

Analyst says Covance execs are smart to back Lab Corp deal

04-Nov-2014 - Lab Corp will buy Covance for $6.1bn in a surprise deal that follows another quarter in which early phase gains were offset by underperformance in central labs.

CRL revs boosted by Argenta and Biofocus; buys ChanTest

30-Oct-2014 - Weaker demand in Europe and Japan saw revenue from Charles River Laboratories' animal models business decline in Q3, but Argenta and BioFocus boosted discovery sales.

MPI Research pushes further into early phase development with CRO acquisition

28-Oct-2014 - MPI Research announced Monday it has acquired the assets of Kalamazoo, Michigan-based CRO Jasper Clinical Research & Development, which provides early-stage human clinical testing of new drugs for an undisclosed amount....

Tail-ored to patients: Horizon latest CRO to offer PDX mouse models

23-Oct-2014 - Horizon is already making plans for the research model company it acquired last month, announcing today it will offer patient-derived xenograft (PDX) models for breast cancer under the Sage Labs...

Mouse model firm Crown builds oncology centre

22-Oct-2014 - Animal-model contract research organisation (CRO) Crown Bioscience will open a research centre in North Carolina, combining expanded oncology services with its existing cardiovascular and metabolic offerings.

MedImmune teams with UK academics on neurodegenerative disease research

16-Oct-2014 - MedImmune’s neurodegenerative disease partnership with the University of Cambridge is about working with “great scientists with great brains” according to a spokeswoman for parent company, AstraZeneca.

Thermo Scientific assesses PK/PD analysis tool after study shows bioequivalence data discrepancies

14-Oct-2014 - Thermo Scientific is assessing its PK/PD data analysis software after a technical paper found discrepancies in results that may have affected drug approvals.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...